TAP2
Antigen peptide transporter 2
Also known as: ABCB3, D6S217E, PSF2, RING11, TAP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q03519
- Gene
- TAP2
- Ensembl
- ENSG00000204267
- Chromosome
- 6
- Canonical length
- 686 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nuclear speckles,Endoplasmic reticulum
OverviewNCBI Gene
The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. This gene is located 7 kb telomeric to gene family member ABCB2. The protein encoded by this gene is involved in antigen presentation. This protein forms a heterodimer with ABCB2 in order to transport peptides from the cytoplasm to the endoplasmic reticulum. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Alternative splicing of this gene produces products which differ in peptide selectivity and level of restoration of surface expression of MHC class I molecules. [provided by RefSeq, Feb 2014]
Canonical amino-acid sequenceUniProt
686 residues, UniProt reviewed canonical sequence.
>Q03519|TAP2
1 MRLPDLRPWT SLLLVDAALL WLLQGPLGTL LPQGLPGLWL EGTLRLGGLW GLLKLRGLLG
61 FVGTLLLPLC LATPLTVSLR ALVAGASRAP PARVASAPWS WLLVGYGAAG LSWSLWAVLS
121 PPGAQEKEQD QVNNKVLMWR LLKLSRPDLP LLVAAFFFLV LAVLGETLIP HYSGRVIDIL
181 GGDFDPHAFA SAIFFMCLFS FGSSLSAGCR GGCFTYTMSR INLRIREQLF SSLLRQDLGF
241 FQETKTGELN SRLSSDTTLM SNWLPLNANV LLRSLVKVVG LYGFMLSISP RLTLLSLLHM
301 PFTIAAEKVY NTRHQEVLRE IQDAVARAGQ VVREAVGGLQ TVRSFGAEEH EVCRYKEALE
361 QCRQLYWRRD LERALYLLVR RVLHLGVQML MLSCGLQQMQ DGELTQGSLL SFMIYQESVG
421 SYVQTLVYIY GDMLSNVGAA EKVFSYMDRQ PNLPSPGTLA PTTLQGVVKF QDVSFAYPNR
481 PDRPVLKGLT FTLRPGEVTA LVGPNGSGKS TVAALLQNLY QPTGGQVLLD EKPISQYEHC
541 YLHSQVVSVG QEPVLFSGSV RNNIAYGLQS CEDDKVMAAA QAAHADDFIQ EMEHGIYTDV
601 GEKGSQLAAG QKQRLAIARA LVRDPRVLIL DEATSALDVQ CEQALQDWNS RGDRTVLVIA
661 HRLQTVQRAH QILVLQEGKL QKLAQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- spleen: 28 nTPM
- esophagus: 23 nTPM
- small intestine: 23 nTPM
- lung: 23 nTPM
- duodenum: 17 nTPM
- vagina: 15 nTPM
Single-cell type
- microglia: 19 nCPM
- oligodendrocyte progenitor cells: 14 nCPM
- astrocytes: 13 nCPM
- brain inhibitory neurons: 10 nCPM
- bergmann glia: 9.6 nCPM
- other brain neurons: 8.6 nCPM
Immune cell
- neutrophil: 8.9 nTPM
- intermediate monocyte: 6.1 nTPM
- non-classical monocyte: 5.9 nTPM
- eosinophil: 5.4 nTPM
- gdT-cell: 4.9 nTPM
- NK-cell: 4.7 nTPM
Brain region
- medulla oblongata: 6.8 nTPM
- thalamus: 6.3 nTPM
- pons: 5.2 nTPM
- hypothalamus: 5 nTPM
- cerebral cortex: 4.5 nTPM
- cerebellum: 4.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TAP2.
Disease | AllUniProt
Conditions TAP2 is implicated in, by any mechanism.
- MHC class I deficiency 2 (MHC1D2) MIM:620813
Disease | GeneticClinVar
26 pathogenic / likely-pathogenic of 511 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- MHC class I deficiency
- MHC class I deficiency 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.39
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antigen processing and presentation of endogenous peptide antigen via MHC class I
- antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent
- antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent
- cytosol to endoplasmic reticulum transport
- peptide antigen transport
- positive regulation of T cell mediated cytotoxicity
- protein transport
- response to molecule of bacterial origin
- T cell mediated cytotoxicity
- transmembrane transport
- antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent
Molecular functions
- ABC-type peptide antigen transporter activity
- ABC-type peptide transporter activity
- ATP binding
- ATP hydrolysis activity
- metal ion binding
- MHC class Ib protein binding
- peptide antigen binding
- peptide transmembrane transporter activity
- TAP1 binding
- tapasin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ABC transporter-like, ATP-binding domain
- AAA+ ATPase domain
- ABC transporter type 1, transmembrane domain
- ABC transporter Tap-like
- ABC transporter-like, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- ABC transporter type 1, transmembrane domain superfamily
- Type 1 protein exporter
- ABC transporter
- ABC transporter transmembrane region
- Antigen peptide transporter 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TAP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TAP2 as an antibody target. Whether an autoantibody or antibody against TAP2 could matter depends on whether native TAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TAP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...